Nexha 10 mg (Hyaluronate Sodium SOLUTION) 10 MG

Nexha 10 mg is a hyaluronate sodium solution used for joint support. This intra-articular solution is designed to aid in lubrication and cushioning of joints, promoting mobility and comfort.

Strength

10 MG

Pack Size

2ML-IA/4ML-IV

Manufacturer / TM Owner

VETOQUINOL N A INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nexha 10 mg is primarily used for intra-articular administration to support joint health. It is often utilized in cases where joint lubrication and cushioning are needed, such as in osteoarthritis or other conditions affecting joint mobility. The hyaluronate sodium in Nexha helps to improve joint function and reduce discomfort associated with joint issues.

Side Effects

When administered intra-articularly, Nexha 10 mg works by providing lubrication and cushioning to the joints. This can help to reduce friction and improve joint movement, potentially leading to increased comfort and mobility. Users may experience improved joint function over time with regular use.

Precautions & Warnings

Nexha 10 mg should be used as directed by a healthcare professional. It is important to follow proper administration techniques to ensure the solution is correctly placed within the joint. Always inform your healthcare provider of any allergies or medical conditions before use.

Avoid Interactions

Nexha 10 mg may interact with other medications or substances. It is advisable to discuss all current medications with a healthcare professional before starting treatment. Avoid using Nexha if you have known allergies to hyaluronate sodium or any of its components.

Frequently Asked Questions

Nexha 10 mg is used for intra-articular administration to support joint health and improve lubrication and cushioning.

Nexha 10 mg should be administered intra-articularly by a healthcare professional to ensure proper placement within the joint.

Nexha 10 mg helps to lubricate and cushion joints, potentially improving mobility and reducing discomfort.

Yes, it is important to follow proper administration techniques and inform your healthcare provider of any allergies or medical conditions.

Nexha 10 mg may interact with other medications, so it is advisable to discuss all current medications with a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.